Natixis Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.24M | Buy |
|
|||||
|
2025
Q2 | $610K | Sell |
|
|||||
|
2025
Q1 | $1.83M | Buy |
|
|||||
|
2024
Q4 | $1.58M | Sell |
|
|||||
|
2024
Q3 | $1.99M | Sell |
|
|||||
|
2024
Q2 | $2.57M | Sell |
|
|||||
|
2024
Q1 | $3.54M | Sell |
|
|||||
|
2023
Q4 | $5.26M | Buy |
|
|||||
|
2023
Q3 | $1.29M | Sell |
|
|||||
|
2023
Q2 | $1.58M | Buy |
|
|||||
|
2023
Q1 | $1.4M | Buy |
|
|||||
|
2022
Q4 | $1.55M | Sell |
|
|||||
|
2022
Q3 | $1.75M | Buy |
|
|||||
|
2022
Q2 | $1.38M | Buy |
|
|||||
|
2022
Q1 | $823K | Sell |
|
|||||
|
2021
Q4 | $1.03M | Buy |
|
|||||
|
2021
Q3 | $705K | Buy |
|
|||||
|
2021
Q2 | $339K | Sell |
|
|||||
|
2021
Q1 | $416K | Sell |
|
|||||
|
2020
Q4 | $392K | Buy |
|